COBI/????? Compass Biotechnologies to Decrease Authorized Share Limit and General Update
SALT LAKE CITY, UT / ACCESSWIRE / December 21, 2015 / Compass Biotechnologies Inc. (OTC PINK: COBI) (COBI) (Compass) Compass Biotechnologies is pleased to announce that the Company recently updated its financial statements and disclosures and is now OTC Pink Current Information status.
The strategic move intended to boost shareholder value, prior to the forthcoming acquisition, will result in the Company reducing the authorized capital share amount to a total of One Billion Shares.
"As the discussions continue with our acquisition target, management believes this will be in the Company and its Shareholders best interests to reduce the authorized capital share limit prior to finalizing the definitive terms of the acquisition,"
remarked Richard Shykora, Interim CEO of Compass. The necessary amendments to be filed with the Secretary of State of Nevada are completed and have been filed and we will await the effectiveness confirmation from the Nevada SOS.
Compass Biotechnologies Inc., (COBI)
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Contact Person:
Richard Shykora
At: compassbiotechnologies@gmail.com
1-972-535-8931
SOURCE: Compass Biotechnologies Inc.
